Skip to content

MDMA: all studies

Page 296 of 345: studies 2,951 to 2,960 of 3,446, newest first. Back to the MDMA overview

Research

Psychedelic use in India, its pattern and personal significance – findings from an online survey

Indian Journal of Psychiatry July 1, 2022 Gokul Raj 3 citations

Sir, Psychedelic studies have reported positive results for depression and anxiety related to cancer and other life-threatening illnesses, treatment-resistant depression, and tobacco and alcohol dependence.[1] Although there are no active psychedelic research studies going on in India, there is growing interest about these substances as evident by numerous social media groups and pages with a...

The Shamanism in Altai and Tuva from past to present: Universal and Local Aspects

Turkic Studies Journal June 22, 2022 Burbar Sukru 1 citation

Shamanism is a system composed of various elements of culture and belief,created by people to understand life and come to grips with what is happeningaround them. It has an elaborate structure in terms of existing in well-roundedcommunities. It has various features that have different aspects compared tothe different times and conditions of the society. It also adopts local beliefsand the...

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

Addiction Neuroscience June 22, 2022 Fúlvio Rieli Mendes, Cristiane Dos Santos Costa, Victor Distefano Wiltenburg et al. 55 citations

Substance use disorder (SUD) is a global public health concern that affects millions of people worldwide. Considering current research, addiction has been noted as the last stage of a chronic disease that may impair brain reward circuit responses and affects personal and social life. Treatments for SUD face challenges including availability and limited pharmacological response, often resulting...

Applying Lessons From Cannabis to the Psychedelic Highway

JAMA Health Forum June 17, 2022 Kevin F. Boehnke, Alan K. Davis, Jenna McAfee 20 citations

In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers.Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of...

The ABC Model of Happiness-Neurobiological Aspects of Motivation and Positive Mood, and Their Dynamic Changes through Practice, the Course of Life.

Biology May 31, 2022 Tobias Esch

Happiness is a feeling, an immediate experience, not a cognitive construct. It is based on activity in the brain's neurobiological reward and motivation systems, which have been retained in evolution. This conceptual review provides an overview of the basic neurobiological principles behind happiness phenomena and proposes a framework for further classification. Three neurobiologically distinct...

0841 Case Report: Can LSD be Associated with Chronic Exploding Head Syndrome?

Sleep May 25, 2022 Feby Puravath Manikat, Clete A. Kushida

Abstract Introduction Exploding head syndrome is a rare phenomenon characterized by a loud imagined noise at sleep onset. Less commonly, it is associated with a simultaneous stab of pain in the forehead. It may result in recurring arousals and anxiety regarding the events. The underlying pathophysiology remains unknown. Report of Cases: A 27 year old male with no past medical history presented...

THE BENEFITS OF PSYCHEDELIC THERAPY FOR MENTAL HEALTH: EXPLORING PSYCHEDELICS

Zenodo (CERN European Organization for Nuclear Research) May 13, 2022 Liliana Irizabal preprint

This project is a systematic review that highlights how beneficial psychedelic psychotherapy can be to those suffering with mental illness. The three mental illnesses chosen to be analyzed in the literature were depression, post-traumatic stress disorder (PTSD), and anxiety. The drugs used in the specific articles included Psilocybin, Ayahuasca(DMT), and MDMA (3,4-methylenedioxymethamphetamine;...

DOI: 10.5281/zenodo.6654351 (opens in new tab) Psilocybin Mental health Psychotherapist Clinical psychology +1

Ketamine: from prescription anaesthetic to New Psychoactive Substance.

Current Pharmaceutical Design May 10, 2022 M. R. Varı̀, G. Ricci, Marco Cavallo et al.

Discovered in the United States of America (USA) in the 1960s, ketamine was introduced as an anaesthetic drug to specifically replace phencyclidine. Briefly, the substance moved from the medical world to recreational users, since it was discovered that intense psychedelic experiences were obtained with dosages lower than those prescribed for anesthesia. At the end of the 90's, circulated in...

Optimal therapy for smokers combines drugs, behavioral support

The Brown University Psychopharmacology Update May 4, 2022

In healthy adults, LSD produces little change in cognition, mood There have been numerous anecdotal reports of beneficial mood and cognitive effects from repeated administration of low doses of lysergic acid diethylamide (LSD) at intervals of 3 to 4 days, but few controlled studies have been conducted. Animal research has suggested that repeated low doses of LSD could confer antidepressant...

Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?

Military Medicine April 21, 2022 Stephan Rudzki 7 citations

ABSTRACT Introduction Treatment outcomes for PTSD with current psychological therapies are poor, with very few patients achieving sustained symptom remission. A number of authors have identified physiological and immune disturbances in Post Traumatic Stress Disorder (PTSD) patients, but there is no unifying hypothesis that explains the myriad features of the disorder. Materials and Methods The...

DOI: 10.1093/milmed/usac095 (opens in new tab) Full text (opens in new tab) Epigenetics Immune system Cytokine Cholinergic +2